Literature DB >> 30789455

Women harmed by vaginal laser for treatment of GSM-the latest casualties of fear and confusion surrounding hormone therapy.

Andrew M Kaunitz1, JoAnn V Pinkerton2, JoAnn E Manson3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30789455      PMCID： PMC6435398          DOI： 10.1097/GME.0000000000001313

Source DB:  PubMed          Journal:  Menopause        ISSN： 1072-3714            Impact factor:   2.953


× No keyword cloud information.
  16 in total

1.  Vaginal estrogen use and chronic disease risk in the Nurses' Health Study.

Authors:  Shilpa N Bhupathiraju; Francine Grodstein; Meir J Stampfer; Walter C Willett; Carolyn J Crandall; Jan L Shifren; JoAnn E Manson
Journal:  Menopause       Date:  2018-12-17       Impact factor: 2.953

2.  Not time to abandon use of local vaginal hormone therapies.

Authors:  JoAnn V Pinkerton; Andrew M Kaunitz; JoAnn E Manson
Journal:  Menopause       Date:  2018-08       Impact factor: 2.953

Review 3.  Genitourinary Syndrome of Menopause.

Authors:  Jan L Shifren
Journal:  Clin Obstet Gynecol       Date:  2018-09       Impact factor: 2.190

Review 4.  Compounded Bioidentical Hormone Therapy: Does the Regulatory Double Standard Harm Women?

Authors:  Cynthia A Stuenkel; JoAnn E Manson
Journal:  JAMA Intern Med       Date:  2017-12-01       Impact factor: 21.873

5.  Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study.

Authors:  Carolyn J Crandall; Kathleen M Hovey; Christopher A Andrews; Rowan T Chlebowski; Marcia L Stefanick; Dorothy S Lane; Jan Shifren; Chu Chen; Andrew M Kaunitz; Jane A Cauley; JoAnn E Manson
Journal:  Menopause       Date:  2018-01       Impact factor: 2.953

6.  The Women's EMPOWER Survey: Identifying Women's Perceptions on Vulvar and Vaginal Atrophy and Its Treatment.

Authors:  Sheryl A Kingsberg; Michael Krychman; Shelli Graham; Brian Bernick; Sebastian Mirkin
Journal:  J Sex Med       Date:  2017-02-12       Impact factor: 3.802

7.  Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2013-09       Impact factor: 2.953

8.  Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: A randomized controlled trial.

Authors:  Mija Blaganje; Darija Šćepanović; Lidija Žgur; Ivan Verdenik; Franja Pajk; Adolf Lukanović
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-03-22       Impact factor: 2.435

9.  Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women.

Authors:  JoAnn V Pinkerton; Nanette Santoro
Journal:  Menopause       Date:  2015-09       Impact factor: 2.953

10.  Why women choose compounded bioidentical hormone therapy: lessons from a qualitative study of menopausal decision-making.

Authors:  Jennifer Jo Thompson; Cheryl Ritenbaugh; Mark Nichter
Journal:  BMC Womens Health       Date:  2017-10-02       Impact factor: 2.809
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.